Skip to main content

finnCap appoints Dr Stephen McGarry to strengthen Life Sciences team

Written by: Editor
Published on: 12 May 2022

finnCapLONDON: 12 May 2022: finnCap Group is delighted to announce the appointment of Dr. Stephen McGarry as Research Director in its Life Sciences team. Stephen is joining the research team to expand the growth trajectory of the franchise following its strong performance over the last two years.

The appointment will strengthen finnCap’s Life Sciences franchise and build upon its leading sector expertise and groupwide capabilities. Against the backdrop of the pandemic, life sciences as a sector continues to innovate and disrupt. The team’s strong sector knowledge and full-service offering enables it to identify and provide the right solutions to meet its clients’ growth needs, whether that be fundraising, M&A, debt or a potential IPO. finnCap currently has 15 life sciences clients and has been a leading adviser in the public life sciences sector for over five years.

The team has a strong track record of capital raising within the sector in both public and private markets, raising over £300m since March 2020.

Stephen has over 20 years’ experience in life sciences. Previously Managing Director and Global Head of Healthcare Research at HSBC Investment Bank, Stephen managed the global healthcare team, covering large and mid cap Pharma and Biotech at both European and US level and coordinating the firm’s healthcare research approach, coverage and valuation methodology across Pharma, Biotech, Medtech, Consumer Health and Healthcare services globally. Prior to this Stephen held roles at Société Générale, Clear River Capital LLP and Goldman Sachs International in London.

Stephen has an extensive background in investment banking and has been the lead analyst in IPOs from Illumina, Intercell and RENOVO. Stephen holds a PhD in Pharmacology and conducted post-doctorate in Research in the Department of Cardiac Medicine, National Heart and Lung Institute at the University of London.

Sam Smith, Chief Executive of finnCap Group, commented: “Stephen’s medical research qualifications and expertise combined with his background in investment banking will make a real difference in helping to bolster our strong-performing life sciences franchise that is seeing a healthy pipeline of activity. We’re looking forward to learning from Stephen as we approach new opportunities for the healthcare businesses of tomorrow.”

Dr. Stephen McGarry, Research Director at finnCap Group said: “Against the backdrop of today’s active market, I’m looking forward to playing a leading role in finnCap’s Life Sciences team. It’s an exciting time to be joining the team with so much corporate activity in the pipeline, and to be involved in working with some truly innovative businesses.”